Bhavin Makwana

Time to get involved: After a morning of insights and reflection, it's time to engage and collaborate with your peers.

Choose a discussion topic. Interact with your peers and identify novel approaches to the challenge confronting you. Each roundtable is led by a subject matter expert. A 10-minute feedback session will follow the discussion.

• TABLE  A: FROM CAPABILITY ASSESSMENT TO CULTURAL FIT: FACTORS TO CONSIDER WHEN SELECTING THE RIGHT CDMO
• TABLE B: THE REGULATORY RADAR: WHAT SHOULD BE ON YOUR WATCHLIST?
• TABLE C:  MOST FAVOURED NATION PRICING: WHAT DOES IT MEAN FOR GLOBAL DRUG ACCESS AND MANUFACTURING?
• TABLE D: THE LIFECYCLE BALANCING ACT: MANAGING COMMERCIAL EXPECTATIONS FOR ESTABLISHED MEDICINES 
• TABLE E: DO PENALTY CLAUSES BUILD BETTER PARTNERSHIPS...OR BREAK THEM?
• TABLE F: HOW MID-SIZED CDMOS CAN ATTRACT BIG PHARMA

Ahead of the conference, we launched a delegate survey to gather insights on what participants hoped to gain from the three-day event, as well as the key challenges currently facing pharma contract manufacturing. The survey explored critical topics such as supply chain disruptions, the impact of geopolitical tensions, and the ongoing debate between localisation and centralisation.